To mark the retirement of Dr Basil C Morson as Consultant Pathologist to St Mark's Hospital, City Road, London, and in recognition of his services to pathology, especially in the colorectal field, an all-day symposium entitled 'The Clinical Pathology of Colorectal Cancer' was held at the Society's House.
The A polyp is broadly defined as any local lesion projecting into the bowel lumen but the pathological type has important implications for the patient. Some are of little clinical consequence, whilst others have malignant potential and place the patient in a group requiring regular colonosoopic-surveillance. The basic classification is into epithelial and connective tissue types but only the former are considered further in this short account (Table 1) .
Although the neoplastic polyps are the most important, the commonest polyps encountered are the metaplastic (hyperplastic) variety but despite being the commonest, little is known about their pathogenesis. There is evidence that the epithelium might be hypermature. They have no malignant potential although their mucin profile is similar to that of adenomas, perhaps indicating at least some common environmental stimulus'.
An interesting and only recently appreciated group ofconditions presenting as polyps are those classified under mechanical stress ( Table 1 ). The basis of the polypoid change is one ofm al prolaps and on this background, polyps of several centimetresdiameter may occur2. At the anal margin these have been termed inflammatory cloacogenic polyps. Polyps as the presentation ofthe solitary ulcer syndrome cause considerable clinical confsion.L Because oftheir malignat potential the neoplastic polyps have the most clinical significance. The worldwide appreciation of this potential is thanks largely to the tireless researchi-and morphological documentation of Basil Motion and encompassed in the 'adenoma-carcinoma'-amuence84. This is the foundation for the clinical management ofneoplastic polyps and cancer prevention e malignant potential Critical to the management of colonic adenomas is the accurate diagnosis of malignancy. In Britain the term carcinoma is used only when dysplastic mucosa is seen invading the muscularis mucosae. It is when this barrier is breached that the lesion has the potential to metastasize having reached. the level of the lymphatics which are limited to the submucosa in the large bowel. If the stalk of the polyp is f-eeof tumour and no tumour is seen in the submucosal lymphatics then clinical experience has shown that local excision is adequate therapy9. It is therefore O141-768/89/ imperative for endoscopists to try and remove polyps 0 whole so that this information is available for the @1.9 pathologist to assess.
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Elsewbere in the gasrointtinaltt adenom us Society of polyps are rare. An interesting question, therfore, Medicine is why dysplastic epithelium in the colon is nearly always polypoid? Flat dysplasia is confined to being a complication of longstanding ulcerative colitis. In the stomach on the other hand, flat dysplasia is the more frequent pattern, with polypoid dysplasia (adenomas) being rare. The easy recognition ofpolypoid versus flat dysplasia means the difference between local polypectomy for early colonic malignancies contrasted with partial gastrectomy for early gastric cancers. Yet early colonic and early gastric cancers have comparable. prognoses. At present there is noadequate explanation for these major variations of dysplastic pattern.
Although some of the risk factors for malignant change in an adenoma are known and have been mentioned, more sensitive ones are needed. Current research in this field encompasses mucin histochemistry, lectin binding, the identification of CEA, DNA aneuploidy by flow cytometry, and oncogene expression. At the present time no one of these techniques seems to offer more than the assessment of the risk factors of polyp size, polyp type and degree of dysplasia outlined earlier and so much more a cornerstone of Basil Morson's work on the adenomacarcinoma sequence. 
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The key paper in the formulation of the adenomacarcinoma sequence was that of Morson1 who postulated that all carcinomas arise in precurser adenomas. He presented evidence in favour of that, and also challenged those who disagreed with him to identify an alternative pathway for colorectal carcinogenesis. The paper reviewed the data from St Mark's Hospital and. showed that whereas small adenomas (less than 10 mm diameter) have a malignant potential of only 1.3% the risk ofmalignancy in large adenomas (more than 20 mm diameter) is more than 40%. Similarly, tubular adenomas have a much lower malignant potential than villous adenomas (with tubulovillous adenomas having an intermediate risk). These results have been confirmed subsequently by many groups. To date, nobody has answered the challenge of Morson and proposed a credible alternative pathway of colorectal carcinogenesis. There have been many autopsy studies carried out in countries with a wide range of incidences of colorectal cancer. These show that the prevalence of colorectal adenomas is about 10-fold higher than the lifetime risk of carcinoma and clearly, therefore, the vast majority of colorectal adenomas remain benign. They also remain small. Whereas small adenomas are evenly distributed along the large intestine most large adenomas arise in the distal colon and rectum (the most common site of carcinomas).
Later, Morson and Konishi2 developed the hypothesis of the adenoma-carcinoma sequence to that of the dysplasia-carcinoma sequence, in order to harmonize it with the observations of dysplasia and carcinoma in other sites, in particular the cervix and the stomach. A more recent review ofcolorectal adenomas by Morson et al.3 has additionally detailed the subsite distribution of adenomas and carcinomas and demonstrates that large adenomas and severe dysplasia tend to occur most often in those subsites that are the commonest locations of carcinomas.
The epidemiological observations on the adenomacarcinoma sequence suggest that colorectal carcinogenesis is a multistage process4 beginning with the formation of a small adenoma. This is the result of environmental factors (termed El); such adenomas are more likely to arise in persons who are genetically 'adenoma-prone' than in the general population. Most adenomas remain small, but some, under the influence of further environmental factors (termed E2), grow to a large size. Although the risk of malignancy in large adenomas is high, a proportion remains benign and so the progression is not inevitable but must be caused; the factor causing this final step is termed C.
In order to learn more ofthe causation of colorectal cancer, we need to identify the factors causing the various stages of the adenoma-carcinoma sequence. Since adenomas are extremely common and only a small proportion are symptomatic, and since there is no system ofregistration of adenomas, we have little evidence with which to identify the causal agents. However, there are three clues. The first is that in a single study, the prevalence of adenomas was shown to be very much higher in alcoholics than in control persons. The second is that, again in a single study which is as yet unconfirmed, there was an association between cigarette smoking and adenoma formation. The third is that in numerous studies the prevalence of adenomas was higher in males than in females. Thus the causes of adenomas are smoking, drinking and sex! The causes of adenoma growth are clearly related to the western lifestyle and particularly to diet. There is some evidence that the factor stimulating the growth of adenomas is a bile acid metabolite produced by the gut bacterial flora, the concentration of which is increased by a high fat/high meat diet and is decreased by a high intake of cereal fibre.
Thne malignant potential of large adenomas is similar in Japanese, Engiish, Swedish and American studies, suggesting a ubiquitous factor. However, in a study of persons with pan.colitis of more than 10 years duration there was evidence that bile acids might be important in this stage also; consequently, dietary factors would be expece to be of importance here and the high malignant potential of large adenomas in Japanese is siply beaue the individas concerned presumably already had the necessary risk factors to cause the formation of the large adenoma.
Undoubtedly each stage in the adenoa-carcinoma sequence has more than one cause4. However, the identification ofthese causal factors is important since carcinogenesis should be preventable by acting at any of the stages.
Dr N A Shepherd outlined the clinical and pathological aspects ofthe polyposis syndromes in his paper:
Polyposis syndromes N A Shepherd MRCPath-Gloucestershire Royal

Hospital, Gloucester
The term polyposis infers ;the presence of multiple polyps in the gastrointestinal tract. There are numerous forms of polyposis syndrome including well known inherited syndromes, familial adenomatous, polyposis (FAP), Peutz-Jeghers polyposis (PJP) and juvenile polyposis (JP). This paper will concentrate on aspects of these syndromes. Iniflammatory polyposis, usually a consequence of chronic inflammatory bowel disease, is the commonest form of polyposis. There are other rare neplastic, hamartomatous and inheri-ted polyposis syndromes.
FAP is the commonest of the-, inherited polyposis syndromes'. Total colectomy and -local control of rectal adenomas ha-ve medlyreduced the incidence of colorectal carcinoma in FAP; the extracolonic manifestations of the disease have become more important in terms of morbidity and mortality.
Gardner described the association of FAP with osteomas of the skull and jaw and epidermal cysts of the skin2. Any extrolonic disease associated with FAP has previously been regarded as a manifestation of Gardner's syndrome. Many would now discourage the use of this term; FAP and Gardner's syndrome probably represent differing manifestations ofthe same genetic defect.
Duodenal carcinoma has become the second commonest cause of death in patients with FAP (after colorectal cancer). Endoscopic duodenal screening has revealed adenomas in at least 50% ofFAP patients by early adulthood. Random biopsies of macroscopically normal duodenal mucosa in these patients will,often show the unicryptal adenomas and microadenomas that are so characteristic of the colorectal mucosa in FAP3. The risk of duodenal carcinoma is sufficiently high to warrant prophylactic endoscopic sceening and removal of adenomas. Desmoids are fibroblastic proliferations, also known as fibromatose, which occur in muscles and aponeuroses. Between6 and 13%o£FAP patients have clinically significant desmoids, usually in the anterior abdominal wall, the mesentery or the; retroperitoneum. They present clinically with an abdominal mass or with small bowel obstruction and are most common in young women. Histologically, desmoids are composed of proliferating fibroblasts with variable collagen formation and often a myxoid stroma. Desmoids in FAP have large and ectatic blood vessels; this accounts for one of the major complications of this disease, massive perioperative haemorrhage.
Peutz first described the association of mucocutaneous pigmentation and gastrointestinal polyposis,in 19214. Jeghers and his colleagues made their classical description of the disease in 19495. The risk of gastrointestinal malignancy in PJP is controversial. in early reviews of the syndrome the lifetime risk varies from 0 to 25%. Epithelial misplacement, which occ'urs in-about 10% of small intestinal polyps, closely mimics adenocarcinomnboth clinically and pathologically and probably accounts for many of the reported cases of cancer in PJP6. This phenomenon is probably the result of intussusception, often a a presenting feature ofthe syndrome. Although PJP is generally thought to be benign, recent reviews would suggest a small but definite risk of gastrointestinal malignancy7 and that most of these carcinomas occur in the upper gastrointestinal tract. However, the risk is sufficiently low to recommend that surgical conservatism be practised.
Juvenile Cancer of the rectum There have been 12 patients (5%), and one further patient followed up elsewvhere who was a poor attender, who have developed a carcinoma in the rectal remnant which gives an esti'mate of the cumulative risk at 25 years of 13%. One might expect that a group of patients under such close surveillance as these with six-monthly sigmoidoscopy would only have early tumours. The Dukes stages have been: A -4 (+1, one patient had two tumours in the specimen); B -3; C -5; and one patient whose tumour histology we have not examined as the operation was performed elsewhere. Two points can be made. The first is that there is a significant cancer risk in the rectal remnant, although the risk is not particularly high even at 25 years, and secondly, that surveillance to date has not been as effective as one might hope in the prevention of more advanced malignancy. Of course, we cannot know what the incidence might have been in the absence of any screening at all. Furthermore, this series largely predates the pouch era and clinicians faced with carpeting of polyps in the rectum had the choice either of excision of the rectum and construction of an end ileostomy or of continuing local attempts at control. Today in similar circumstances a pouch would likely be offered somewhat earlier.
Other complications
The rectum has subsequently been removed other than for cancer in 11 patients (4%), desmoid tumours have arisen in 15 (6%), and upper gastrointestinal malignancy has occurred in 11 (4%).
The surgical choices are:
(1) Proctocolectomy and ileostomy. This abolishes the risk of subsequent large bowel cancer but at the price of a stoma. As many of these patients are young and often uinmarried they are understandably not keen on this option, and what is more worrying, the children of patients treated in this way may well default when they become aware of what is in store for them.
(2) Proctocolectomy and ileoanal pouch. This also abolishes the risk of subsequent colorectal cancer but with a much better quality of life for the patient. The functional result is probably not as good as after an ileorectal anastomosis (IRA) and complications are much more frequently seen. The Leeds Castle Polyposis Group examined the results ofeither an IRA constructed for polyposis (536 patients) or ofa pouch (94 patients) and found an overall complication rate of 7.4%-in the former and 34% in the latter. (3) Colectomy and ileorectal anastomosis. This reduces the risk ofsubsequent large bowel cancer but does not abolish it. It also simplifies surveillance. The anastomosis should be constructed level with the sacral promontory. It is not necessary at the initial operation to clear the rectal stump of polyps as many regress oftheir own accord after colectomy and ileorectal anastomosis.
Conclusion
At St Mark's Hospital we would still favour colectomy and ileorectal anastomosis as the first treatment, and especially in the younger patient, but we would be quite ready to offer a pouch where the perceived risk These considerations led naturally to the topic of the second morning session, 'Cancer Prevention', chaired by Professor G Slavin.
Professor J Hardcastle presented an update on the screening of populations for the early diagnosis of carcinoma of the large bowel by the detection of haemoglobin in the faeces. He outlined the several systems in use and explained the difficulties with patient and practitioner compliance. The cost of such a scheme has to be evaluated against the cost of treatment late in the disease. In the long-term and with suitable education, this should prove to be a simple and effective means ofreducing the mortality from bowel cancer.
Dr C B Williams stressed the value of endoscopic examination of the colon and rectum for the detection and removal of polyps for histological examination. With finite resources and the limited numbers of skilled operators available to carry out this work, the value of cancer registries is apparent when considering who in the general pc examined in this way.
Dr G T Williams reviewed the Dr Morson in showing the import ulcerative colitis. He showed that I significance of these cellular cho indicators in deciding on early surg thus in preventing the developme Having calculated the empiric risks from Lovett's pedigrees we decided nearly two years ago that we could use the information to identify a high-risk population who, because of their family experience, might be interested in screening for colorectal cancer.
Webasedthe screeningmrz me on Basil Morson's mpulation should be hypothesis that premalignant polyps preceded malignant change2, giving an opportunity to identify the pioneering work of polyps by colonoscopy and a posgibility ofprevention by ance of dysplasia in removing the polyps. With Dr Christopher Williams the recognition and we decided that a life time risk of 1 in 10 or greater mnges are valuable was an appropriate level of risk to offer colonoscopy "Cal treatment, and and that this should be offered every five years from ,nt-of frank cancer. ages 25 to 60. We decided to repeat colonoscopy every three years if polyps were found. Family members per of the pre-lunch with estimated risks less than 1 in 10 were offered annual screening by Haemoccult test.
We opened a Family Clinic at St Mark's Hospitalabout 20 months ago. The-Imperial Cancer Research Fund have supported this project and they publicized ee Hospital, Pond the clinic in their own circulations-and in the press.
It is an open clinic; we do not demand a referral letter but we write to family doctors when we have seen the patients. Table 2 shows the total number of patients who have come to the clinic and their source of it in' 1976,' Eileen referral.
British Journal of Table 3 shows the estimated risks of the patients jase in risk of death we have seen. In 5% we were unsure of the risks for legree relatives of patients attending St Mark's Hospital with cancer of the rectum or colon. She also noted that the increased risk was particularly high in relatives ofpatients who developed their cancer under the age of 45 and drew attention to an unexpected incidence of cancer in other sites, particularly a two-fold increase in stomach cancer in men and a similar increase in both stomach and breast cancer in women.
The incidence of colorectal cancer in the population of England and Walesis 1 in 40 and the death rate is 1 in 50. With these apparently disppointingresults of detection and treatment the condition calls for an effort in prevention.
Dr Morson's hypothesis that most colorectal cancer starts in a premalignant adenoma suggests that there may be a latent premalignant stage which gives an opportunity for prevention and it was with this in mind that we decided to re-examine the Lovett pedigrees and calculate the actual risks to first degree relatives ofpatients presenting with colorectal cancer. Table 1 shows the result.
When the relatives are themselves related there is various reasons. At first we were not sure how to interpret the contribution of other cancers in the family and sometimes there was not enough information available to assess the risk. Two hundred and sixty-nine patients at risk greater than 1 in 10 were offered colonoscopy and will be regularly followed up. Table 4 shows the results of the first 20 months of the screening programme, the total yield of polyps being 24 (9%) out of 269 patients.
So far it has not been possible to interpret the significance ofthese findings. The incidence ofpolyps is no different from the 10% incidence reported in postmortem series, but these reported incidences are from populations over 60 years ofage. The mean age of the 24 patients in whom polyps were found in our screened population was 48.6 years, the youngest being 29 years. Five were parents at risk and aged between 62 and 77 years. The mean age of the siblings in whom polyps were found was 40.5 years. It is too early to know whether we have identified a group of patients with a high frequency of adenomatous polyps and it is impossible to know whether their risk of developing cancer can be reduced. Indeed, it would be difficult, in view of Lovett's findings, to make a randomized trial of a screening programme as the patients identified through a young affected first degree relative start with an increased probability of colorectal cancer, even before the polyps are found.
Among the relatives at lower risk, 142 have been found to have an estimated risk between 1 in 17 and 1 in 10 and have been given their first Haemoccult test kit. One hundred and thirty-four have returned them. One was positive, preceded by colonoscopy and was found to have adenomatous polyps which were removed.
Perhaps the most interesting group of families examined were the 99 families in which the family tree showed evidence of dominant inheritance of malignant disease (Table 5 ). Dominantly inherited site specific colon cancer was evident in 38 pedigrees. The risks of colon cancer to first degree relatives in these families is 1 in 2 and screening by colonoscopy is very strongly indicated. Most of them, though not all, exemplify the adenoma carcinoma sequence which Basil Morson described. Forty-four patients gave family histories compatible with the Family Cancer Syndromes described by Lynch3. It is these families which are reflected in Lovett's observations of the increased risk of stomach cancer in male and female relatives and ofbreast cancer in the female relatives of her consecutive series of patients with colorectal cancer; suggesting that the family cancer syndrome, presenting as colorectal cancer is more common than is often suspected. We have noted among other cancers a high frequency of breast and ovarian cancers as well as other gastrointestinal cancers in the female relatives and now feel that female family members should be offered mammography and ultrasound screening of their ovaries. We have identified six new and unsuspected families with familial adenomatous polyposis presenting with early onset of colorectal cancer in a first degree relative, and nine other families with multiple cancers, benign breast and thyroid lumps, sebaceous cysts and basal cell naevae. In these families it was difficult to distinguish Gorlin syndrome or Cowden's disease from the Muir-Torre syndrome. In two families, multiple lipomata were observed with colon cancer.
Nearly 20 000 men and women die from colorectal cancer in England and Wales each year. Using the South Thames Cancer Register, it can be estimated that just over 700 would be expected to be diagnosed under 45 years of age each year, and in 1985, 686 died before 50. These patients could lead to the identification of 4500 first degree relatives each with a lifetime risk of death from colorectal cancer greater than 1 in 10, and hence 450 are expected to die from colorectal cancer representing 2.25% of the total burden in the population.
The proportion ofthe total death rate from colorectal cancer in the population is small but judging by the referral pattern of the St Mark's Family Cancer Clinic, the affected families are aware of the risk, anxious to be screened and glad of a plan of action.
Members of families with site specific colon cancer or Family Cancer Syndromes are at the highest risk and may not be as rare as indicated in the rather specialized literature. I would like to suggest that it is always worth taking a family tree from young patients with colorectal cancer. It could lead to a real opportunity of prevention in unsuspected high risk members of the population.
References. At St Mark's Hospital about 35% ofpatients operated on for rectal cancer die with recurrent disease despite the fact that the operation was considered to-be curative. Usually, this is due torecurrence at distant sites with or without local recurrence. It is most unusual for patients to die with local recurrence only. Evidence suggests that recurrence at distant sites such as the liver is due to the presence ofestablished though occult metastasis at the time of surgery. There are no reliable methods of detecting such metastases but their presence might be predicted by a pathobiological classification. One could derive such a classification by identifying those variables that predict cancer-related death independently. Such a classification would differ from the traditional method of Dukes. The latter records the extent of local and lymphatic spread within a surgical specimen. A pathobiological classification would be concerned with the prediction of occult distant spread in patients having curative surgery fr rectal cancer,.
Specimens from 379 patients who had undergone curative surgery for rectal cancer more than 20 years previously were re-examined in order to identify tumour characteristics" having an inidependent influence on long term survival. The selected variables included the number of involved lymph nodes, character ofthe invading margin ofthe growth, extent of lymphocytic infiltration and whether or not the tumour was limited to the bowel wall. These variables were given weighted scores and the score range was divided to provide four prognostic groups. The model was tested on a second set of 331 patientsand gave similar results. The new prognostic classification is simple to use and is superior to staging by the method of Dukes because it places twice as many patients within groups that provide a confident prediction of clinical outcome.
There is growing interest in the concept of a clinicopathological classification. Clinical input is mainly of importance in allowing a distinction to be made between curative and non-curative surgery. However, there should always be histological confirmation of metastasis or residual cancer within the bed ofthe tumour. More importantly, the surgical specimen should be carefully studied to exclude the presence of cancer at the deep excision line. Thus both clinical and pathological data will determine whether an operation is classified as curative or non-curative. The concept of local excision for adenocarcinoma of the rectum is not new. It-had been practised at the end ofthe last century and the beginning of this and in 1940 Lockhart-Mummaryl in writing on local excision stated that 'the growth should be quite small and localised to the bowel in cases where a more extensive operation is for some *eason or other impossible'. This clinical statement essentially summarizes the present indications for local eision which, even in-modern practice, start with the digital examination ofthe tumour per rectum. Local excision has remained of little interest until recent years and at St Mark's, presently, about-6% of large bowel tumours treated are removed by this method. These include both colonoscopic as well as formal surgical removals.
Current indications contain the essence of the clinical features stated above, but owing to a greater knowledge of the pathological spread of rectal adenocarcinoma the clinical indications have become more precinely defined. Morson, in 19662, laid downpathological criteria for local excision. These were based on factors which indicated whether regional spread was likely already to have taken place or not. Regional lymph node metasta were likely where the growth was poorly differentiatend in about 50% ofcases in which the tumour-had invadedthrough the bowel wall into the extrarectal tissues. They were least likely where the growth was confined to the ectal wall and histological grade was not anaplastic. This led to the formation of a policy for localexcision combining both clinical findings and pathological assessment of the excised specimen. Digital examination per rectum can identify growths confined to the rectal wall with an accuracy of about 70%3. Endoluminal ultrasound is more accurate with rates of 90% or more having been reported4'5. Based on these assessments, the preoperative criteria for local excision include a tumour less than 30 mm in diameter which is mobile and where the preoperative biopsy does not show a poorly differentiated growth. There must be no palpable lymph node metastases. Local excision can be carried out as both a curative and a palliative procedure. When curative it should be regarded as an alternative to total rectal excision only. Patients suitable for anterior resection should be treated by this procedure. Palliative cases include those patients who are unfit for major surgery and those who have a locally confined tumour but are also suffering from disseminated disease.
The policy of local excision has to be vindicated by histopathological examination of the resected specimen. The surgeon should therefore present the excised tumour in a suitable manner for cutting by pinning it out on a cork. b.oard before fixation. The pathological criteria for maintaining the policy of local excision then include completeness of excision, the absence of penetration of the rectal wall, the absence of lymphatic or venous invasion and the absence of poor differentiation. If any ofthese are not found to be present, then early major surgery is indicated in curative cases.
In a review of all patients undergoing local excision for rectal cancer between 1948 and 1978 at St Mark's Hospital, the 5 year survival rates were available. Patients with familial adenomatous polyposis and those treated by radiotherapy were excluded. A total of 52 patients were identified. Six were lost to follow-up within the five year period, leaving 46 available for study. All patients had an ulcerating sessile carcinoma which was diagnosed as such. preoperatively. The patients were divided into three groups. In group 1, local excision was carried out as a curative procedure in patients otherwise. requiring a total rectal excision. Group 2 included patients who were unfit for major surgery owing to thepoor general condition. Group 3 included patients in whom local excision was employed as a means of obtaining local clearance where disseminated disease was already recognized.
The majority of operations were carried out via. an endoanal approach. The growth was excised with a.margin of 10 mm of normal mucosa and the resulting defect sutured. Excision involved the full thickness of the rectal wall. Group 1: there were 27 patients in this group including 11 men and 16 women with an average age of 64 years. There was one postoperative death leaving 26 available for follow-up. In 24 patients, the policy of local excision was fulfilled and in 19 ofthese all clinical and histological criteria for local excision were present and no further surgical procedure was carried out. Five patients underwent further major surgery on the basis of the histological examination postoperatively. In the 24 patients in whom the policy of local excision was fulfilled, there were two cancerrelated deaths within five.-years (8%). Two other patients in group 1 refused major surgery and.thus broke the policy of local excision. Both ultimately required a total rectal excision and both died of disseminated disease at 5 and 4.5 years.
Group 2: there were 13 patients in this group, with the policy fulfilled in seven. Two were alive at five years and four had died of other disease with no evidence of recurrence. The seventh patient underwent early major resection and was alive and free of recurrence at five years. In the six patients in whom the policy was not fulfilled,-four underwent no further surgery but only one died of cancer. The remaining two patients required salvage surgery for recurrence at 8 and 24 months. None of these six patients were alive at five years but only two had died *of cancer. Group 3: there were six patients in this group, of whom three required major surgery for local tumour control. All the patients were dead within five years of treatment and in only two patients was local excision successful in maintaining local control.
These results demonstrate that with a combination of clinical and histopathological assessment, it is possible to identify a small group of-patients in whom surgical treatment for cure can be achieved where a total rectal excision with permanent colostomy would otherwise be required. The results of local excision as curative treatment in this selected group of patients have yielded a cancer specific survival of 92%. and justify the policy6. , it is now possible to preserve the anal sphincter in a far greater number of patients with low rectal cancers than was previously the case. Whereas these new techniques deal adequately with upward spread, there is concern that they are not as effective as APER in dealing with down ward and lateral spread. For many years, it was considered that in order to remove microscopic intramural distal spread, it was necessary to excise a rectal carcinoma with a minimum distal clearance of 50 mm. Thia'5 cm rule' was enshrined in the surgical literature2 following reports at the beginning ofthis century of a few cases in which microscopic distal spread was demonstrated. In order to investigate the frequency ofthis problem, we studied 50 APER specimens by-taking multiple sections distal to the macroscopic edge of the tumour3. Twelve cases (24%) had evidence of distal intramural spread, but only five (10%) had spread greater than 15 mm. Each ofthese fiv-e tumours were Dukes Cl or C2 lesions and were histologically poorly differentiated. Despite the treatment ofthese tumours by the most radical operation, namely APER, each of the five patients with distal spread greater than 15 mm was dead from distant metastases, not local recurrence, within three years ofthe operation. It appears, therefore, that if distal spread ofthis degree is present, the tumour is biologically advanced and surgical treatment, no matter how radical, cannot hope to cure it. Furthermore, retrospective studies comparing survival and recurrence rates in patients who had undergone anterior resection with a distal margin of clearance of more or less than 50 mm revealed no significant differences.
For these reasons, since 1978 we,-like others, have abandoned the '5 cm rule' and reduced the distal margin of clearance to a minimum of 20 mm in those cases where a greater margin woud. mean sacrifice of the anal sphincter. We have compared our 74 patients who underwent 'radical' SSR for low rectal growths between 1978 and 1982 with a historical control group who underwent APER for similar tumours4. The patients were matched for age and sex. Cumulative five-year survival and recurrence rates were not significantly different in the two groups. Thus, it seems reasonable to reduce the distal m margin of clearance to 20 mm if the only other alternative would be to sacrifice the anal sphincter.
Whereas much has been written on distal spread, there is little in the literature on lateral or radial spread. We therefore investigated this problem in 52 patients who had undergone rectal excision (26 APER; 26 SSRP. Microscopic lateral spread was looked for by serial transverse slicing and microscopic examination of whole mount sections of the entire tumour. Spread to the lateral resection margin was demonstrated in 20 patients (30%). Ten had undergone APER and 10 had undergone SSR. Overall, 15 of 20 patients (75%) (8 APER and 7 SSR) with lateral tumour invasion have recurred, whereas only one of 38 patients (3%) without lateral tumour invasion has recurred (P<0.01). Eleven patients (52%) with radial spread had been considered by the-surgeon-to have had a curative operation. The ount oftissue removed in the lateral direction as measured from the macroscopic edge of the tumour in the course of an APER [7 mm (range 0.22 mm)] was not significantly different from that removed during SSR [10mm (0-25 mm)].
These data show, therefore, -that the incidence of lateral spread is frequently underestimated ry both surgeon and pathologist, that such spread is the main cause of local recurrence, and that a correctly performed SSR is jiust as effective in removing it as an APER. Such data can also explain the considerable surgeon to surgeon variation in the rates of local recurrence after low SSR6.
Our pathological studiee thus support the view that -the anal sphincter should be prrved whenever technically feasible -even if this moansthiat the, minimal margin of distal clearincet is rei'dIerom 50 m to 20 mm.-However, improvemett in Athe results of surgery will only occur if the residual microscopic disease which resultsfrom lateral spread is dealt with more effectively. This may be achieved by a greater concentration on surgical technique and the more frequent use of adjuvant radiotherapy. Staging of rectal cancer depends on soft tissue imaging to show the extent of local spread, invasion of adjacent structures, lymph node involvement and metastases to the liver. Computed tomography (CT) and rectal endosonography (RES) have both been compared to digital assessment of local spread. In 33 patients1 digital assessment was 64% accurate compared to 84% for CT and 96% for RES. This compares favourably with other series where digital assessment was 69% and 67-83% accurate compared to 94 and 89% for CT2. Rectal endosonography is more sensitive than CT for demonstrating invasion beyond the muscularis propria as this can be clearly defined on RES as an echo-poor black ring, with tumour also hypoechogenic, whereas the muscle layer cannot be defined on CT and wall thickening has to be > 10 mm before tumour spread outside the wall is apparent. Computed tomography is superior, however, in defining invasion ofthe pelvic side wall structures as RES does not penetrate this far. Perirectal lymph nodes can be visualized ion RES, but the criteria for invasion have not been determined. Less than 73% of involved nodes have; been visualized, and a significant number of false positives reported3.
Computed tomography can show enlarged lymph nodes, which are considered involved if >15 mm.
About 29% of resections -will have occult liver metastases not apparent at laparotomy4. Imaging hepatic metastases relates to their size. Lesions >20mm should be detectable by either CT or ultrasound (US), although sometimes metastases are isodense or badly placed for detection. Lesions 10-20 mm in size are at the threshold level for detection. Magnetic resonography may prove superior to CT. Various enhancement techniques can be used to improve CT but recently contrast agents have also been developed for magnetic resonography. However as yet the only method for detecting lesions< 10 mm is by intra-operative sonography. Rectal endosonography is an excellent modality for detecting local recurrence. In 22 cases, RES detected each recurrence and in six cases was the only positive examination compared with clinical, endoscopic, CT and CEA studies3.
Indium labelled anti-CEA monoclonal antibody provides a possible mode of imaging the primary, involved lymph nodes as well as distant metastases, but at present is still in the research stage awaiting the ideal antibody.
In conclusion, RES is superior to CT and digital assessment for the local spread of rectal cancer, but all imaging techniques are inadequate in detecting early lymph node involvement. Rectal endosonography is the examination of choice for local recurrence. Magnetic resonography will almost certainly prove superior to CT and US for hepatic assessment, but as yet the threshold for occult metastases remains at 10-20 mm lesions.
After tea, a guest lecture was delivered by Professor N A Wright entitled 'Differentiation in Colorectal Cancer: Prospects for Reversing the Malignant Phenotype'. He gave us a fascinating insight into the ultimate cancer prevention technique by genetic manipulation of the undesirable genotype.
The academic programme was concluded with a eulogy of the guest of honour by Professor J E Lennard-Jones, 'Basil C. Morson, An Appreciation.' A review of the early life, scholastic attainments, scientific achievements, honours, international recognition, serviceto country and community ofthis man of humour and compassion was admirably and wittily delivered.
In the evening a dinner was held at the Royal College of Surgeons of England. Over one hundred guests of national and international fame wished the principal guest well in his retirement.
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